LATEST PODCAST:  Escape the Scale-Up Trap - Redefining Manufacturing Strategies    Listen now!
Contact Us
Contact Us

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

Graphic depiction of messenger RNA up close

4 min read

AGC Biologics partners with Child’s Cure Genetic Research to pursue mRNA-based therapeutic for severe epileptic disorder

November 10, 2026 at 6:00 AM
Press Release mRNA Content
Read press release
Exterior of building at AGC Biologics Copenhagen site

2 min read

Global Pharmaceutical Company Commits to a Dual-Site Deal with AGC Biologics Exceeding €0.5 Billion

November 3, 2026 at 12:00 AM
Mammalian & mAbs Press Release cGMP
Read press release
An AGC Biologics employee examines a large vial.

3 min read

Flen Health Chooses AGC Biologics to Manufacture Recombinant Enzymes for Next-Generation Wound Treatment

September 24, 2026 at 12:00 AM
Press Release Tech Transfer Microbial
Read press release

2 min read

AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars

July 28, 2026 at 6:00 AM
Mammalian & mAbs Press Release Business Updates
Read press release

2 min read

AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services

June 30, 2026 at 9:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release

2 min read

AGC Biologics to Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance

May 25, 2026 at 5:00 PM
Press Release Tech Transfer Microbial
Read press release
Logos of AGC Bio and Orphan Therapeutics shown to reflect new network partnership

2 min read

AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases

May 11, 2026 at 5:00 AM
Cell & Gene Therapy Press Release
Read press release
AGC Biologics and Novelty Nobility leaders meet to discuss GMP manufacturing of bispecific drug candidate, NN4101 in Tokyo, Japan on April 13, 2026.

2 min read

Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate

May 3, 2026 at 4:45 PM
Mammalian & mAbs Press Release Cell Line Development
Read press release
Image showing award logo

3 min read

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

April 27, 2026 at 8:30 AM
Read press release

2 min read

AGC Biologics Seattle site now certified to manufacture biologics for largest pharmaceutical market in South America

February 3, 2026 at 8:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
1 2 3 4 5 Next